August 3, 2010

Over-the-Counter Medicines May Still Be Eligible

On March 23, 2010, President Obama signed legislation to overhaul the nation's health care system.  Included in the new law are changes to eligible Over-the-Counter expenses for pre-tax accounts including FSA, HRA and HSA plans.

Beginning January 1, 2011, a provider’s directive note (prescription) will be needed for over-the-counter (OTC) medicines, drugs and biological treatments to be reimbursed through an FSA, HRA or HSA and cannot be purchased using the PreTax debit card.

For example:

If you currently (in 2010) use your Pre-Tax debit card to purchase OTC Advil, effective January 1, 2011, you will no longer be able to use your Pre-Tax debit card to purchase the Advil. 

Instead, you must first obtain a medical providers directive (prescription) stating that you need Advil to treat your medical condition, then you may purchase the Advil using after-tax dollars (cash, check or another credit or debit card).

Submit both your receipt and prescription to HR Simplified for reimbursement.

On January 1, 2011, the Pre-Tax debit card will still work for other OTC products such as bandages, durable medical supplies,blood-pressure monitoring devices,crutches, diabetic supplies and many other OTC non-medicines.

Over-the-counter medicines, drugs and biological treatments are about 35 percent

of the current eligible OTC list.

Only those items that represent drugs, medicines and biologicals require a provider’s directive. The items affected include items in the following categories:

 

Acid Controllers

Allergy & Sinus

Antibiotic Products

Anti-Diarrheals

Anti-Gas

Anti-Itch & Insect Bite

Antiparasitic Treatments

Baby Rash

Ointments/Creams

Cold Sore Remedies

Cough, Cold & Flu

Digestive Aids

Feminine Anti-Fungal/Anti-Itch

Hemorrhoidal Preps

Laxatives

Motion Sickness

Pain Relief

Respiratory Treatments

Sleep Aids & Sedatives

Stomach Remedies

Click here to support efforts underway to encourage elimination of the pending OTC restriction.

 

Return to Home Page

Go To All News